|
C11ORF30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.90069984593333E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59110002950769E-09 |
| Normal-vs-Stage2 |
2.378500E-03 |
| Normal-vs-Stage3 |
2.174800E-04 |
| Normal-vs-Stage4 |
5.17509999964361E-07 |
| Stage1-vs-Stage2 |
6.665000E-01 |
| Stage1-vs-Stage3 |
7.608600E-01 |
| Stage1-vs-Stage4 |
3.300600E-01 |
| Stage2-vs-Stage3 |
5.559600E-01 |
| Stage2-vs-Stage4 |
1.900190E-01 |
| Stage3-vs-Stage4 |
4.791600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.92560009341037E-10 |
| Normal-vs-AfricanAmerican |
2.02220000000697E-06 |
| Normal-vs-Asian |
8.187700E-02 |
| Caucasian-vs-AfricanAmerican |
7.686800E-01 |
| Caucasian-vs-Asian |
7.217200E-01 |
| AfricanAmerican-vs-Asian |
6.287000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.75077746639363E-12 |
| Normal-vs-Female |
3.920400E-02 |
| Male-vs-Female |
7.617200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.33799999991436E-07 |
| Normal-vs-Extreme_Weight |
1.96859972767527E-10 |
| Normal-vs-Obese |
3.89560000000344E-05 |
| Normal-vs-Extreme_Obese |
1.160130E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.070400E-01 |
| Normal_Weight-vs-Obese |
2.852200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.041800E-01 |
| Extreme_Weight-vs-Obese |
7.333500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.790400E-01 |
| Obese-vs-Extreme_Obese |
6.086400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.444100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.64680000003248E-06 |
| Normal-vs-Age(61-80Yrs) |
9.58390034000445E-11 |
| Normal-vs-Age(81-100Yrs) |
2.8058999568259E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.899800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.031600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.090500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.598500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.358200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.234340E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.31819996532323E-09 |
| Normal-VS-Type2 PRCC |
1.42874601039011E-12 |
| Normal-VS-KIRP CIMP |
3.661000E-01 |
| Normal-VS-Unclassified PRCC |
8.483500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.780290E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.390600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.679000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.491600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.277700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.277000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.48410206135941E-11 |
| Normal-vs-N1 |
1.478280E-02 |
| Normal-vs-N2 |
4.963400E-04 |
| N0-vs-N1 |
1.382760E-01 |
| N0-vs-N2 |
9.516600E-01 |
| N1-vs-N2 |
4.912000E-01 |
|
|
